4 results
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
SGLT2i in HF and CKD ... HF outcomes in HFrEF ... HF outcomes in HFrEF ... SGLT2 #inhibitors #EBM ... #table #CVD #CKD
Guideline-Directed Medical Therapy (GDMT) in HFrEF and CKD

 • Class I pillars of HFrEF GDMT across
Guideline-Directed ... ) in HFrEF and CKD ... used in HFrEF: ... Statins, Thiazides ... #CKD #HFrEF #management
Stages in the development of HF and recommended therapy by stage. ACEI indicates angiotensin-converting enzyme inhibitor;
angiotensin-receptor blocker; CAD ... ejection fraction; GDMT ... , guideline-directed ... heart failure; HFpEF ... ejection fraction; HFrEF
HFpEF and CAD Management Algorithm
1. Consider revascularization based on current guidelines for CAD and HFpEF*
2. Statins:
HFpEF and CAD Management ... for CAD and HFpEF ... Statins: all patients ... Enroll in HFpEF ... #HFpEF #CAD #Management